Lundbeck
HLUN-B.CO
#2706
Rank
โ‚น617.18 B
Marketcap
โ‚น622.07
Share price
0.19%
Change (1 day)
29.00%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): โ‚น66.53 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น3.80 Billion. , an increase over its 2024 earnings that were of โ‚น52.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น73.36 B38.47%
2024 โ‚น52.98 B25.74%
2023 โ‚น42.13 B21.77%
2022 โ‚น34.60 B31.57%
2021 โ‚น26.30 B-4.61%
2020 โ‚น27.57 B-45.06%
2019 โ‚น50.18 B-34.04%
2018 โ‚น76.09 B12.83%
2017 โ‚น67.44 B93.99%
2016 โ‚น34.76 B-137.28%
2015 -โ‚น93.26 Billion-1246.24%
2014 โ‚น8.13 B-72.36%
2013 โ‚น29.43 B4.38%
2012 โ‚น28.19 B-55.18%
2011 โ‚น62.91 B5.65%
2010 โ‚น59.55 B-5.9%
2009 โ‚น63.28 B